These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7126358)

  • 1. [In vitro effect of culture fluids from neoplastic tissues on platelet aggregation. I. Human tumors of the gastrointestinal tract].
    Pacchiarini L; Serra L; Grignani G; Gamba G; Gorini M
    Boll Soc Ital Biol Sper; 1982 Jul; 58(13):847-53. PubMed ID: 7126358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro effect of culture fluids from neoplastic tissues on platelet aggregation. II. Experimental tumors].
    Pacchiarini L; Serra L; Grignani G; Gamba G; Gorini M
    Boll Soc Ital Biol Sper; 1982 Jul; 58(13):854-9. PubMed ID: 7126359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human blood platelet aggregation and the stimulation of nitric oxide synthesis by aspirin.
    Chakraborty K; Khan GA; Banerjee P; Ray U; Sinha AK
    Platelets; 2003; 14(7-8):421-7. PubMed ID: 14713511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pentoxifylline on platelet aggregation.
    Nenci GG; Gresele P; Agnelli G; Ballatori E
    Pharmatherapeutica; 1981; 2(8):532-8. PubMed ID: 7255510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of some antineoplastic drugs (vincristine, doxorubicin and epirubicin) on human platelet aggregation.
    Matera C; Falzarano C; Vacca C; Falciani M; Rossi F
    J Med; 1994; 25(1-2):2-16. PubMed ID: 7930957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists.
    Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R
    Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro.
    Nunn B
    Thromb Haemost; 1981 Feb; 45(1):1-5. PubMed ID: 7245119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of U46619 induced human platelet aggregation by aspirin.
    Kim JM; Koo YK; Jin J; Lee YY; Park S; Yun-Choi HS
    Platelets; 2009 Mar; 20(2):111-9. PubMed ID: 19235053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acetylsalicylic acid on aggregation of human platelets by Porphyromonas gingivalis.
    Whitaker EJ; Thomas IS; Falk JA; Obebe A; Hammond BF
    Gen Dent; 2007; 55(1):64-9; quiz 70, 79-80. PubMed ID: 17333971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of naftidrofuryl on platelet aggregation in plasma from aspirin treated patients: an in vitro study.
    Le Dévéhat C; Khodabandehlou T; Mosnier M
    Clin Hemorheol Microcirc; 2000; 22(3):197-204. PubMed ID: 10976713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute, moderate ethanol consumption on human platelet aggregation in platelet-rich plasma and whole blood.
    Zhang QH; Das K; Siddiqui S; Myers AK
    Alcohol Clin Exp Res; 2000 Apr; 24(4):528-34. PubMed ID: 10798590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erythrocytes modulate the anti-aggregation effect of aspirin and dipyridamole. Study under static conditions and in a flow system].
    Bozzo J; Hernández MR; Ordinas A
    Sangre (Barc); 1996 Feb; 41(1):13-8. PubMed ID: 8779028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hematocrit on adenosine diphosphate-induced aggregation of human platelets in tube flow.
    Goldsmith HL; Kaufer ES; McIntosh FA
    Biorheology; 1995; 32(5):537-52. PubMed ID: 8541523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
    Serebruany VL; Malinin AI; Sane DC
    Am J Hematol; 2003 Apr; 72(4):280-1. PubMed ID: 12666142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effect of ethanol on ADP and collagen-induced platelet aggregation.
    Bengmark S; Elmér O; Göransson G; Zoucas E
    Thromb Haemost; 1981 Dec; 46(4):673-5. PubMed ID: 7330816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nafamostat mesilate on ADP-induced platelet aggregation and disaggregation in hemodialysis patients.
    Miyata M; Shirakawa T; Acharya B; Terao S; Gotoh A
    ASAIO J; 2006; 52(3):272-5. PubMed ID: 16760715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.